The influence of perioperative enoxaparin on bleeding after TORS oropharyngectomy

J Robot Surg. 2024 May 7;18(1):203. doi: 10.1007/s11701-024-01965-z.

Abstract

Perioperative enoxaparin is often avoided in patients undergoing transoral robotic (TORS) oropharyngectomy. Our goal was to quantify the risk of postoperative hemorrhage (POH) in patients receiving enoxaparin after TORS oropharyngectomy. This was a retrospective database cohort study set up in 89 separate healthcare organizations. The TriNetX electronic database was queried for patients with OPSCC who underwent TORS oropharyngectomy. Propensity-score matching was used to create two cohorts, one receiving and one not receiving perioperative enoxaparin. Outcome measures were the POH rate within 1 day of surgery ("primary") and POH rate within 2-30 days of surgery ("secondary"). 1109 patients undergoing TORS for OPSCC were identified, 400 of which received perioperative enoxaparin. One-to-one propensity score matching resulted in 310 patients per cohort. After matching, the primary POH rates between patients receiving and not receiving enoxaparin were 3.23% for both cohorts (OR 1.000, 95% CI 0.410 to 2.438). The secondary POH rates between those receiving and not receiving enoxaparin were 5.47% vs. 3.54% (OR 1.577, 95% CI 0.726 to 3.424). The number needed to harm (NNH) with perioperative enoxaparin use for secondary POH after TORS was 53; no difference was found in primary POH rates. While not statistically significant, the use of perioperative enoxaparin after TORS is associated with increased odds of secondary POH with a NNH of 53; no difference was found in rates of primary POH. For patients undergoing TORS, enoxaparin use requires careful weighing of the risks and benefits.

Keywords: Complications; Enoxaparin; Oropharyngectomy; Postoperative hemorrhage; Trans-oral robotic surgery.

MeSH terms

  • Aged
  • Anticoagulants* / administration & dosage
  • Anticoagulants* / adverse effects
  • Enoxaparin* / administration & dosage
  • Enoxaparin* / adverse effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oropharyngeal Neoplasms / surgery
  • Oropharynx
  • Perioperative Care / methods
  • Postoperative Hemorrhage* / epidemiology
  • Postoperative Hemorrhage* / prevention & control
  • Propensity Score
  • Retrospective Studies
  • Robotic Surgical Procedures* / adverse effects
  • Robotic Surgical Procedures* / methods

Substances

  • Enoxaparin
  • Anticoagulants